Skip to main content
Premium Trial:

Request an Annual Quote

Swan Song


Legend has it that the mute swan — a white swan found mainly in Europe and Asia, though it has been introduced into the Americas — is silent all its life. Then, just as it is about to die, it sings the most beautiful song.

It's just a legend, though. Mute swans actually make a soft snorting sound — it's not unpleasant, but neither is it particularly pretty. But the notion of its deathbed song has taken hold as a metaphor for a last act before the end.

Here, I present to you Genome Technology's swan song, its last act before the end. After 12 years, Genome Technology will cease monthly print publication with this issue. It was a difficult and fraught, yet ultimately necessary, decision to say that this is the end of the line.

It goes out, though, facing the future, with profiles of two dozen up-and-coming investigators intent on making their mark on the life sciences community in fields as varied as clinical cancer sequencing and gene splicing and public health genomics. Their best days are likely ahead.

Like the legend of the swan song isn't true, this issue won't truly be the end of GT. Its content will live on, incorporated into the coverage found at There, readers will still be able to enjoy GT-style features — including the popular salary survey and, yes, future incarnations of the up-and-coming investigators — and other coverage of the field. Our subscriptions team will be in touch with you soon to help you ensure that you continue to have access to such content. If you're not already registered at, I encourage you to do so.

Lastly, let me say that it has been a real pleasure speaking and interacting with the systems biology and genomics research community. These are exciting times to be in — or to be writing about — this field of biology. Change is coming, and sometimes it is difficult, but it is always necessary. I look forward to continuing to cover the field and its challenges, though in a slightly different format.

Without further ado, here is our song. Let us hope that this last act is a beautiful one, or at least one with some sort of snorting sounds.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.